Pyxis Oncology PYXS
NASDAQ PYXS
$1.64 +0.01 (+0.61%)
At close: Nov 11, 2026 · 4:00 PM EST

Pyxis Oncology (PYXS) Non-Current Deferred Tax Liability (2023 - 2024)

Updated

Pyxis Oncology (PYXS) reported Non-Current Deferred Tax Liability of $2.16 million for Q3 2024, unchanged from the prior quarter.

Analysis

Pyxis Oncology (PYXS) Non-Current Deferred Tax Liability (2023 - 2024) Analysis & Trends

Dating back to Q4 2023, Pyxis Oncology's Non-Current Deferred Tax Liability record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q3 2024 came in at $2.16 million (Q2 2024), $2.16 million (Q1 2024) and $2.16 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pyxis Oncology 136.12 Mn -60.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 2.16 Mn
Jun 30, 2024 2.16 Mn
Mar 31, 2024 2.16 Mn
Dec 31, 2023 2.16 Mn
API Access

Pyxis Oncology Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=PYXS&period=max&api_key=YOUR_API_KEY